Articles Archives - ISR Market Research

Articles News

News: ramarketing acquires US market research firm ISR

Strategic life sciences marketing agency ramarketing has completed the acquisition of ISR Market Research, a specialist agency based in North Carolina’s Research Triangle Park (RTP), one of the largest pharmaceutical and biopharma hubs in North America. The deal strengthens ramarketing’s…

Brandon Allison

Articles Clinical Trials Manufacturing

Performance Benchmarking Informs Service Provider Selection

Selecting a CMO or CRO is stressful, expensive, and time-consuming. The complexity of these supplier organizations makes them difficult to evaluate. Far too often, decision makers lack vital information to support selection decisions. But the consequences of selecting the wrong…

Kevin Olson

Articles Custom Research

How Services Marketers Can Own Their Performance Measures

Services marketers are often not evaluated on actual marketing performance. The lack of objective and relevant performance measures can limit respect for the marketing function and influence within the organization, and that’s problematic. Instead, services marketers are often evaluated on…

Kevin Olson

Articles Custom Research

How Services Marketers Can Build a Strong Marketing Strategy

Is your services marketing strategy constantly being questioned, critiqued, and disrupted internally? Too often, marketers lack vital information to create an effective marketing strategy and your organization and department suffer due to constant disruption of marketing plans. You, as a…

Kevin Olson

Articles Custom Research

The Importance of Market Research & Why You Don’t Use It

Let’s set the scene: You’ve got a project. It’s probably not the most important thing you or your company will do this year but it’s meaningful. There’s a real chance to move the needle with this one. Maybe you’re considering…

Kevin Olson

Articles

Decentralized Clinical Trials: Evolving Post-Pandemic

Decentralized clinical trials (DCTs) are studies in which some or all trial-related activities are conducted at a location separate from the investigators’ primary site. DCTs’ numerous benefits include convenience and flexibility for patients, greater opportunities for patient recruitment, increased patient…

Laura McWhinney

Articles

Sponsor Perspectives on Outsourced Clinical Trial Logistics

ISR consistently seeks to demystify the mystical, and there’s plenty of mystery regarding clinical trial logistics. How do sponsors select a provider? Which activities do they outsource the most? Where are these questions heading? To none other than ISR’s latest…

Brandon Allison

Articles

Highly Potent API Manufacturing

Highly potent API manufacturing is a rapidly growing segment of drug development. Those familiar with HPAPI understand its specialized nature and the strict regulations surrounding it. A complicated and resource-intensive process, sponsors often find themselves in need of knowledgeable outsourcing…

Brandon Allison

Articles

Commercial Bioprocessing Market Outlook

Choosing an outsourcing partner for a commercial bioprocessing endeavor carries a gravitas that those outside that endeavor may not appreciate. Equally significant is the challenge facing CMOs in this space, many of whom are competing against larger, well-known manufacturers with…

Brandon Allison

Articles

Cell & Gene Market Outlook

I bet you can’t say “cell & gene therapies” three times fast. And by the time you do, you’ll have missed another article on your newsfeed discussing their intricacies and the headaches they can cause. Here’s one from Industry Standard…

Brandon Allison

Articles

CTMS Benchmarking & Market Dynamics

ISR’s CTMS Benchmarking & Market Dynamics (3rd Ed.) aims to tackle clinical trial management systems (CTMS) by helping providers and sponsors alike better understand current trends surrounding this technology and anticipate future ones. This report is the result of primary…

Brandon Allison

Articles

Six Questions to Ask About Your Market Research

How do you ensure the research products and services you buy will make you confident in the decisions you make? Here are six reasons why Industry Standard Research ensures you are getting the value you should expect from quality market…

Brandon Allison

Articles

2019 Year In Review – An Overview Of Insights in Pharmaceutical Manufacturing, Clinical Research and Technology

How Pharma, CROs, and CDMOs can prepare for 2020 ISR conducted approximately two dozen individual pieces of market research for syndication in 2019. This webinar summarizes many of the important learnings from these projects, providing attendees with real, usable data…

Brandon Allison

Articles

Influence Of Size In CRO Selection

Vice President of Market Research at Industry Standard Research Rebecca McAvoy discusses whether the company size of a CRO has an impact on its therapeutic expertise, and by extension, an impact on outsourcing selection. CRO selection. Whether you’ve been in…

Brandon Allison

Articles

Decision-Makers Agree—Phase I Clinical Research is Becoming More Complex

Informing pharmaceutical drug developers, manufacturers, and service providers Raleigh, N.C. — October 16, 2018 — Industry Standard Research (ISR) announces the release of its newest report, “Phase I Study Trends and Market Outlook (2018-2022),” in which 143 Phase I decision-makers…

Brandon Allison